Rates of vaccination for the human papillomavirus are on the rise among children in the U.S., but still fall short of national goals.
Harvard Chan School's Barry Bloom discusses the coronavirus vaccine development process and how to persuade people to get vaccinated.
Research fellow Stephen Kissler discussed the past six months of coronavirus response in Massachusetts as well as what to expect in the next six.
Positive early trial results from two coronavirus vaccine candidates are “very exciting,” according to Harvard Chan School's Barry Bloom.
A foundation of public trust and social solidarity needs to be there for a COVID-19 vaccine to be widely accepted.
Although COVID-19 cases, hospitalizations, and deaths are rising, there is also some positive news on the horizon, according to Harvard Chan School's Joseph Allen.
Fifteen health and legal experts called President Trump’s move to withdraw the U.S. from the World Health Organization “reckless,” in violation of U.S. law, and a threat to global health and security.
Companies and researchers racing to develop a COVID-19 vaccine will encounter numerous challenges as they try to understand how the immune system reacts to the virus that causes the disease. A June 10, 2020 Harvard Magazine article examined…
While vaccines for COVID-19 are urgently needed, the public would do well to realize that vaccines will not simply prevent all infections. It’s more likely that any vaccines developed will reduce the risk for contracting the disease and…
Perspective: COVID-19 highlights pressing need to better understand immunity, particularly in elderly
The COVID-19 pandemic has highlighted the vulnerability of aging populations to emerging diseases and underscores the significant need to better understand immunity and vaccine response among the elderly, according to an April 17, 2020 New England Journal of…